| Title: | Circulating metabolite biomarkers: a game changer in the human prostate cancer diagnosis |
| Author(s): | Krishnan S; Kanthaje S; Punchappady DR; Mujeeburahiman M; Ratnacaram CK; |
| Address: | "Yenepoya Research Centre, Yenepoya (Deemed to Be University), University Road, Deralakatte, Mangaluru, 575018, Karnataka, India. Department of Urology, Yenepoya Medical College Hospital, Deralakatte, Mangaluru, 575018, Karnataka, India. Department of Urology, Yenepoya Medical College Hospital, Deralakatte, Mangaluru, 575018, Karnataka, India. mujeeburahiman@gmail.com. Yenepoya Research Centre, Yenepoya (Deemed to Be University), University Road, Deralakatte, Mangaluru, 575018, Karnataka, India. rckoumar@yenepoya.edu.in" |
| DOI: | 10.1007/s00432-022-04113-y |
| ISSN/ISBN: | 1432-1335 (Electronic) 0171-5216 (Linking) |
| Abstract: | "PURPOSE: Prostate cancer (PCa) is the second most commonly diagnosed cancer in men in Western and Asian countries. Serum prostate-specific antigen (PSA) test has been the routine diagnostic method despite the tremendous research in diagnostic markers for early detection of PCa. A shift towards a promising and potential biomarker for PCa detection is through metabolomic profiling of biofluids, particularly the blood and urine samples. Finding reliable, routinely usable circulating metabolite biomarkers may not be a distant reality. METHODS: We performed a PubMed-based literature search of metabolite biomarkers in blood and urine for the early detection of prostate cancer. The timeline of these searches was limited between 2007 and 2022 and the following keywords were used: 'metabolomics', 'liquid biopsy', 'circulating metabolites', 'serum metabolite', 'plasma metabolite', and 'urine metabolite' with respect to 'prostate cancer'. We focussed only on diagnosis-based studies with only the subject-relevant articles published in the English language and excluded all of the other irrelevant publications that included prostate tissue biomarkers and cell line biomarkers. RESULTS: We have consolidated all the blood and urine-based potential metabolite candidates in individual as well as panels, including lipid classes, fatty acids, amino acids, and volatile organic compounds which may become useful for PCa diagnosis. CONCLUSION: All these metabolome findings unveil the impact of different dimensions of PCa development, giving a promising strategy to diagnose the disease since suspected individuals can be subjected to repeated and largescale blood and urine testing" |
| Keywords: | "Male Humans *Prostate/metabolism Biomarkers, Tumor/metabolism Early Detection of Cancer/methods *Prostatic Neoplasms/diagnosis Biomarkers Liquid Biopsy Blood and urine Circulating biomarkers Mass spectroscopy Metabolomics Prostate cancer diagnosis;" |
| Notes: | "MedlineKrishnan, Sabareeswaran Kanthaje, Shruthi Punchappady, Devasya Rekha Mujeeburahiman, M Ratnacaram, Chandrahas Koumar eng YU/Seed Grant/ 090-2020/Yenepoya Deemed to be University/ Review Germany 2022/06/29 J Cancer Res Clin Oncol. 2023 Mar; 149(3):951-967. doi: 10.1007/s00432-022-04113-y. Epub 2022 Jun 28" |
